bluebird bio, Inc.
BLUE · NASDAQ
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Revenue | $38,712 | $38,521 | $10,612 | $16,101 |
| % Growth | 0.5% | 263% | -34.1% | – |
| Cost of Goods Sold | $12,237 | $22,789 | $11,781 | $28,946 |
| Gross Profit | $26,475 | $15,732 | -$1,169 | -$12,845 |
| % Margin | 68.4% | 40.8% | -11% | -79.8% |
| R&D Expenses | $17,721 | $20,844 | $23,174 | $25,162 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $30,261 | $31,395 | $39,765 | $50,385 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $3,100 | -$49 | $2,811 | $0 |
| Operating Expenses | $51,082 | $52,190 | $65,750 | $75,547 |
| Operating Income | -$24,607 | -$36,458 | -$66,919 | -$88,392 |
| % Margin | -63.6% | -94.6% | -630.6% | -549% |
| Other Income/Exp. Net | -$4,362 | $7,853 | $6,053 | $7,020 |
| Pre-Tax Income | -$28,969 | -$28,605 | -$60,866 | -$81,372 |
| Tax Expense | $100 | $107 | -$58 | $21 |
| Net Income | -$29,069 | -$28,712 | -$60,808 | -$81,393 |
| % Margin | -75.1% | -74.5% | -573% | -505.5% |
| EPS | -2.98 | -0.45 | -0.95 | -1.27 |
| % Growth | -562.2% | 52.6% | 25.2% | – |
| EPS Diluted | -2.98 | -0.45 | -0.95 | -1.27 |
| Weighted Avg Shares Out | 9,751 | 64,110 | 64,110 | 64,110 |
| Weighted Avg Shares Out Dil | 9,751 | 64,110 | 64,110 | 64,110 |
| Supplemental Information | – | – | – | – |
| Interest Income | $612 | $1,162 | $1,640 | $2,837 |
| Interest Expense | $5,743 | $5,704 | $5,778 | $5,453 |
| Depreciation & Amortization | $15,543 | $13,905 | $15,344 | $16,526 |
| EBITDA | -$7,683 | -$8,996 | -$39,744 | -$59,393 |
| % Margin | -19.8% | -23.4% | -374.5% | -368.9% |